Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Mind Medicine Mindmed Inc (MNMD)
Mind Medicine Mindmed Inc (MNMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 127,502
  • Shares Outstanding, K 40,095
  • Annual Sales, $ 0 K
  • Annual Income, $ -56,800 K
  • 60-Month Beta 2.40
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.46
Trade MNMD with:

Options Overview Details

View History
  • Implied Volatility 129.68% ( -16.31%)
  • Historical Volatility 86.53%
  • IV Percentile 90%
  • IV Rank 44.44%
  • IV High 228.24% on 11/14/23
  • IV Low 50.83% on 10/09/23
  • Put/Call Vol Ratio 3.48
  • Today's Volume 444
  • Volume Avg (30-Day) 484
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 90,025
  • Open Int (30-Day) 88,225

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.47
  • Number of Estimates 3
  • High Estimate -0.44
  • Low Estimate -0.49
  • Prior Year -0.27
  • Growth Rate Est. (year over year) -74.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.41 +33.40%
on 11/13/23
3.84 -16.28%
on 12/04/23
+0.52 (+19.52%)
since 11/08/23
3-Month
2.41 +33.40%
on 11/13/23
4.51 -28.71%
on 09/12/23
-0.78 (-19.42%)
since 09/08/23
52-Week
2.12 +51.65%
on 12/29/22
5.01 -35.83%
on 07/18/23
+0.55 (+20.86%)
since 12/08/22

Most Recent Stories

More News
3 Stocks Under $10 Analysts Expect to Double

Here's a closer look at three low-priced stocks - MNMD, ASPN, and BEEM - that Wall Street is expecting to double (or more) from current levels.

MNMD : 3.24 (+1.89%)
ASPN : 12.70 (+8.73%)
BEEM : 5.30 (+5.37%)
Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise

/PRNewswire/ -- The demand for abuse deterrent formulation technology is projected to grow due to growing misuse of drugs among the people. Growing demand for...

NTRBW : 0.3899 (+5.38%)
CYBN : 0.4099 (-1.23%)
NTRB : 2.50 (+2.04%)
CMND : 3.24 (-13.83%)
MNMD : 3.24 (+1.89%)
LLY : 595.93 (+1.30%)
Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise

EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:CMND),(NASDAQ:MNMD),(NYSE:CYBN),(NYSE:LLY) EQNX::TICKER_END

NTRB : 2.50 (+2.04%)
NTRBW : 0.3899 (+5.38%)
CMND : 3.24 (-13.83%)
MNMD : 3.24 (+1.89%)
CYBN : 0.4099 (-1.23%)
LLY : 595.93 (+1.30%)
The Breakthrough Therapy Aiming To Solve The World’s Mental Health Crisis

EQNX::TICKER_START (NYSE:JNJ),(NYSE:ABBV),(NASDAQ:ATAI),(NASDAQ:CMPS),(NASDAQ:MNMD) EQNX::TICKER_END

ABBV : 149.88 (+1.29%)
ATAI : 1.2150 (+3.85%)
CMPS : 6.55 (+9.53%)
MNMD : 3.24 (+1.89%)
JNJ : 154.63 (-0.50%)
Global Psychedelic Therapeutics Market Size Expected To Reach $13.29 Billion By The Year 2031

EQNX::TICKER_START (NYSE:CYBN),NEO:CYBN),(NASDAQ:CMPS),(NASDAQ:MNMD),(NASDAQ:SEEL),(OTCQX:NUMIF) EQNX::TICKER_END

CYBN.NE : 0.5600 (unch)
MMED.NE : 4.4100 (+2.56%)
CYBN : 0.4099 (-1.23%)
CMPS : 6.55 (+9.53%)
SEEL : 1.6700 (-1.18%)
MNMD : 3.24 (+1.89%)
NUMIF : 0.0807 (+0.75%)
NUMI.TO : 0.1050 (-4.55%)
Global Psychedelic Therapeutics Market Size Expected To Reach $13.29 Billion By The Year 2031

/PRNewswire/ -- Psychedelic and hallucinogenic medicines market have been growing consistently over the past several years and are expected to continue to rise...

NUMI.TO : 0.1050 (-4.55%)
CYBN : 0.4099 (-1.23%)
CMPS : 6.55 (+9.53%)
MNMD : 3.24 (+1.89%)
SEEL : 1.6700 (-1.18%)
NUMIF : 0.0807 (+0.75%)
Cedar Clinical Research, by Numinus, the top enrolling clinical research site for MindMed's Phase 2B study evaluating MM-120

/PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and...

MNMD : 3.24 (+1.89%)
NUMI.TO : 0.1050 (-4.55%)
NUMIF : 0.0807 (+0.75%)
MindMed Reports First Quarter 2023 Financial Results and Business Highlights

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders,...

MMED.NE : 4.4100 (+2.56%)
MNMD : 3.24 (+1.89%)
MindMed Sends Letter to Shareholders Highlighting Company’s Positive Momentum and Value-Enhancing Strategy

The Board of Directors (the “Board”) of Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product...

MMED.NE : 4.4100 (+2.56%)
MNMD : 3.24 (+1.89%)
INCY : 54.95 (-0.42%)
SGEN : 219.50 (+0.54%)
PFE : 28.82 (+0.66%)
FBRX : 0.5800 (+0.02%)
JAZZ : 120.49 (+0.79%)
ALC : 72.08 (+0.25%)
MindMed to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business Update

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or "MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders,...

MMED.NE : 4.4100 (+2.56%)
MNMD : 3.24 (+1.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Mind Medicine Inc. is a clinical-stage psychedelic medicine biotech company. It discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. Mind Medicine Inc. is based in New York, United States.

See More

Key Turning Points

3rd Resistance Point 3.90
2nd Resistance Point 3.75
1st Resistance Point 3.46
Last Price 3.24
1st Support Level 3.03
2nd Support Level 2.89
3rd Support Level 2.60

See More

52-Week High 5.01
Fibonacci 61.8% 3.91
Fibonacci 50% 3.57
Last Price 3.24
Fibonacci 38.2% 3.22
52-Week Low 2.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar